Patent: 6,440,423
✉ Email this page to a colleague
Summary for Patent: 6,440,423
| Title: | Mutant enterotoxin effective as a non-toxic oral adjuvant |
| Abstract: | Methods and compositions are provided herein for the se of a novel mutant form of E. coli heat-labile enterotoxin which has lost its toxicity but has retained its immunologic activity. This enterotoxin is used in combination with an unrelated antigen to achieve an increased immune response to said antigen when administered as part of an oral vaccine preparation. |
| Inventor(s): | Clements; John D. (New Orleans, LA), Dickinson; Bonny L. (New Orleans, LA) |
| Assignee: | The Administrators of the Tulane Educational Fund (New Orleans, LA) |
| Application Number: | 09/365,530 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,440,423
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Biologicals | HAVRIX | hepatitis a vaccine inactivated | Injection | 103475 | 02/22/1995 | ⤷ Try a Trial | 2014-08-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
